Launch One Acquisition - Unit | 10-Q: FY2025 Q2 EPS: USD 0.07

EPS: As of FY2025 Q2, the actual value is USD 0.07.

Interest Earned on Trust Account: For the three months ended June 30, 2025, interest earned was $2,547,714, and for the six months ended June 30, 2025, it was $4,996,750.

Net Income: For the three months ended June 30, 2025, net income was $1,922,018, compared to a net loss of $22,202 for the same period in 2024. For the six months ended June 30, 2025, net income was $4,209,431, compared to a net loss of $40,388 for the period from February 21, 2024, through June 30, 2024.
General and Administrative Expenses: For the three months ended June 30, 2025, expenses were $637,837, and for the six months ended June 30, 2025, they were $815,879.

Net Cash Used in Operating Activities: For the six months ended June 30, 2025, net cash used in operating activities was - $586,598.

Unrealized Gain on Marketable Securities: For the three months ended June 30, 2025, the unrealized gain was $11,999, and for the six months ended June 30, 2025, it was $28,221.

Core Business Focus: The company is focused on completing the Minovia Business Combination, which involves merging with Minovia Therapeutics Ltd. and becoming a wholly-owned subsidiary of Pubco, a publicly traded company on Nasdaq.
Non-Core Business: The company is also working on securing bridge financing agreements and additional transaction financing to support the business combination with Minovia.

EPS: As of FY2025 Q2, the actual value is USD 0.07.

Interest Earned on Trust Account: For the three months ended June 30, 2025, interest earned was $2,547,714, and for the six months ended June 30, 2025, it was $4,996,750.

Net Income: For the three months ended June 30, 2025, net income was $1,922,018, compared to a net loss of $22,202 for the same period in 2024. For the six months ended June 30, 2025, net income was $4,209,431, compared to a net loss of $40,388 for the period from February 21, 2024, through June 30, 2024.
General and Administrative Expenses: For the three months ended June 30, 2025, expenses were $637,837, and for the six months ended June 30, 2025, they were $815,879.

Net Cash Used in Operating Activities: For the six months ended June 30, 2025, net cash used in operating activities was - $586,598.

Unrealized Gain on Marketable Securities: For the three months ended June 30, 2025, the unrealized gain was $11,999, and for the six months ended June 30, 2025, it was $28,221.

Core Business Focus: The company is focused on completing the Minovia Business Combination, which involves merging with Minovia Therapeutics Ltd. and becoming a wholly-owned subsidiary of Pubco, a publicly traded company on Nasdaq.
Non-Core Business: The company is also working on securing bridge financing agreements and additional transaction financing to support the business combination with Minovia.